The impact of laparoscopic surgical treatments on oncologic outcome of Stage I uterine leiomyosarcoma

Background: Morcellation may worsen the outcome of occult uterine leiomyosarcoma (uLMS), while the effect of laparoscopic surgery itself, without morcellation, on the oncological outcomes of patients with early stage uLMS is also currently unknown. Materials and Methods: A retrospective analysis of 75 patients who underwent treatment for Stage I uLMS at Shanghai Cancer Center was per-formed. Kaplan–Meier and Cox proportional hazards regression models were used for analyses. Results: Fifty-five patients underwent primary open surgery and 20 underwent laparoscopy. Patient age was significantly lower in the laparoscopy (44 ± 9.04 years) compared with the open surgery group (50.85 ± 9.96 years) (p < 0.007). Laparoscopic surgery was associated with shorter overall survival (OS) according to Kaplan–Meier (KM) log-rank test (p = 0.046), and multivariate Cox regression ([ = 0.032, RR = 2.423, 95% confidence interval, 1.081–5.429), but not disease-free survival (DFS) (p = 0.682, Kaplan–-Meier log-rank test). In stratification analysis, patients who underwent laparoscopic total hysterectomy/modified radical hysterectomy (without morcellation ) had shorter DFS (p = 0.006) and OS (p = 0.001), compared with the open group. However, laparoscopic myomectomy and sub-total hysterectomy were associated with a similar DFS (p =0.924) and OS (p =0.580) to open total hysterectomy/modified radical hysterectomy. There was no significant difference in DFS (p = 0.941) or OS (p = 0.737) between laparoscopic surgery with and without morcellation. Conclusions: Laparoscopic surgery may be associated with poorer survival than open surgery in patients with early stage uLMS, even in the absence of morcellation.

Uterine leiomyosarcoma; Laparoscopy; Recurrence; Survival.

[1] Momtahen S., Curtin J., Mittal K.: “Current Chemotherapy and Po-tential New Targets in Uterine Leiomyosarcoma”. J. Clin. Med. Res., 2016, 8,181.

[2] Seagle B.L., Kanis M., Kocherginsky M., Strauss J.B., Shahabi S.: “Stage I uterine carcinosarcoma: Matched cohort analyses for lym-phadenectomy, chemotherapy, and brachytherapy”. Gynecol. Oncol., 2017, 145, 71.

[3] Ricci S., Stone R.L., Fader A.N.: “Uterine leiomyosarcoma: Epi-demiology, contemporary treatment strategies and the impact of uter-ine morcellation”. Gynecol. Oncol., 2017, 145, 208.

[4] Hensley M.L., Barrette B.A., Baumann K., Gaffney D., Hamilton

A. L., Kim J.W., Ray-Coquard I.: “Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas”. Int. J. Gynecol. Cancer, 2014, 24, S61.

[5] Wen K.C., Horng H.C., Wang P.H., Chen Y.J,. Yen M.S., Ng H.T., Taiwan Association of Gynecology Systematic Review G.: “Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review”. Taiwan J. Obstet. Gynecol., 2016, 55, 463.

[6] Bogani G., Chiappa V., Ditto A., Martinelli F., Donfrancesco C., In-dini A., Raspagliesi F.: “Morcellation of undiagnosed uterine sar-coma: A critical review”. Crit. Rev. Oncol. Hematol., 2016, 98, 302.

[7] Raspagliesi F., Maltese G., Bogani G., Fuca G., Lepori S., De Iaco P., Lorusso D.: “Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study”. Gynecol. Oncol., 2017, 144, 90.

[8] Raine-Bennett T., Tucker L.Y., Zaritsky E., Littell R.D., Palen T., Neugebauer R., Lentz S.E.: “Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Mor-cellation”. Obstet. Gynecol., 2016, 127, 29.

[9] Bogani G., Cliby W.A., Aletti G.D.: “Impact of morcellation on sur-vival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis”. Gynecol. Oncol., 2015, 137, 167.

[10] Liu F.W., Galvan-Turner V.B., Pfaendler K.S., Longoria T.C., Bris-tow R.E.: “A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature”. Am. J. Obstet. Gynecol., 2015, 212, 717.

[11] Volz J., Koster S., Spacek Z., Paweletz N.: “The influence of pneu-moperitoneum used in laparoscopic surgery on an intraabdominal tumor growth”. Cancer, 1999, 86, 770.

[12] Matsuzaki S., Bourdel N., Darcha C., Dechelotte P.J., Bazin J.E., Pouly J.L., Canis M.: “Molecular mechanisms underlying postoper-ative peritoneal tumor dissemination may differ between a laparo-tomy and carbon dioxide pneumoperitoneum: a syngeneic mouse model with controlled respiratory support”. Surg. Endosc., 2009, 23, 705.

[13] He H., Zeng D., Ou H., Tang Y., Li J., Zhong H.: “Laparoscopic treat-ment of endometrial cancer: systematic review”. J. Minim. Invasive Gynecol., 2013, 20, 413.

[14] Bogani G., Borghi C., Leone Roberti Maggiore U., Ditto A., Sig-norelli M., Martinelli F., Raspagliesi F.: “Minimally Invasive Surgi-cal Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis”. J. Minim. Invasive Gynecol., 2017, 24, 552.

[15] Palomba S., Falbo A., Russo T., La Sala G.B.: “Port-site metastasis after laparoscopic surgical staging of endometrial cancer: a system-atic review of the published and unpublished data”. J. Minim. Inva-sive Gynecol., 2012, 19, 531.